Akynzeo
(netupitant / palonosetron)Akynzeo 235 MG / 0.25 MG in 20 ML InjectionAkynzeo 235 MG / 0.25 MG Injection
View 1 more
NO BLACK BOX WARNING
Dosage & administration
biomarker testing
Akynzeo clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
drug label
Akynzeo prescribing information
patient education
Akynzeo patient education
Getting started on Akynzeo
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Learn More
Other resources
Learn More
people also ask
Akynzeo FAQs
How is the dosage of Akynzeo?Akynzeo is available in 3 dosages, including 11.75-0.0125 mg/ml Injection 20 ml, 235-0.25 mg Injection and 300-0.5 mg Cap
What does Akynzeo treat?Akynzeo treats
What is Akynzeo made of?Akynzeo contains netupitant / palonosetron which is a Serotonin-3 Receptor Antagonist
How Is Akynzeo Administered?Akynzeo is administered as a Injectable or Oral Pill
What Are The Akynzeo Mechanism Of Action?Akynzeo mechanism of action is Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 3A4 Inhibitors, Neurokinin 1 Antagonists, P-Glycoprotein Inhibitors or Serotonin 3 Receptor Antagonists
FAQ Data Source